Abstract
Genetic polymorphisms of drug metabolism can affect phase I and phase II reactions. Polymorphisms of cytochrome P450 activity or inducibility have been implicated in drug toxicity and in cancerogenesis. Polymorphisms of the detoxification processes may be important in the appearance of adverse responses to conventional doses of drugs. Pharmacogenetics now opens new ways to investigate the relations between genetic factors, xenobiotics and teratogenesis.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
